Literature DB >> 28739738

Cyclophilin A Is Overexpressed in Hepatocellular Carcinoma and Is Associated with the Cell Cycle.

Zhaohua Gong1, Cheng Chi1, Xiaojuan Huang2, Hongjin Chu3, Jiahui Wang3, Fengcai Du1, Lixin Jiang4, Jian Chen5,3.   

Abstract

AIM: To investigate the expression of cyclophilin A (CypA) in human hepatocellular carcinoma (HCC) and explore the effects of CypA on the cell cycle in HCC.
MATERIALS AND METHODS: CypA expression was assessed by immunohistochemistry in 48 cases of HCC tissues and paired adjacent tissues. CypA plasmid was transfected into HCC cells and the cell cycle was analyzed.
RESULTS: Positivity for CypA was higher in HCC tissues than in adjacent tissues (79.1% vs. 12.5%, p<0.05). Positivity for CypA was significantly higher in stage III and IV HCC than in stage I and II (p<0.05). Elevated CypA induced an increase of the percentage of S-phase cells (from 34.79% to 42.14%) and a decrease of G0-G1 phase cells (from 58.10% to 50.64%).
CONCLUSION: CypA is overexpressed in HCC and is associated with TNM stage. CypA also appears to promote the transition of the cell cycle from G1 to S phase. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CypA; cell cycle; hepatocellular carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28739738     DOI: 10.21873/anticanres.11839

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.

Authors:  Hong-Ye Jiang; Gang Ning; Yen-Sheng Wang; Wei-Biao Lv
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA-mRNA regulation network.

Authors:  Rui Hao; He Lu; Yanan Guo; Qianqian Liu; Lu Wang; Yang Wang; Ailong Huang; Zeng Tu
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  [Expression of cyclophilin A in oral squamous cell carcinoma and its effect on cell proliferation and invasion].

Authors:  Xiao-Yang Xia; Fei Fang; Yan Liu; Chao Che; Jin-Juan Ke; Sheng-Jun Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

4.  Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis.

Authors:  Joseph Kuo; Sonia Simón Serrano; Alvar Grönberg; Ramin Massoumi; Magnus Joakim Hansson; Philippe Gallay
Journal:  Front Pharmacol       Date:  2019-09-26       Impact factor: 5.810

Review 5.  Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy.

Authors:  Jang Mi Han; Hye Jin Jung
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

6.  Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma.

Authors:  Sonia Simón Serrano; Michele Tavecchio; Josef Mallik; Alvar Grönberg; Eskil Elmér; Chamseddine Kifagi; Philippe Gallay; Magnus Joakim Hansson; Ramin Massoumi
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

7.  Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.

Authors:  Kaku Goto; Hironori Nishitsuji; Masaya Sugiyama; Nao Nishida; Masashi Mizokami; Kunitada Shimotohno
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

8.  Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer.

Authors:  Zhanrui Mao; Hui Zhao; Yulan Qin; Jianming Wei; Jielin Sun; Weiwei Zhang; Yani Kang
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.